DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

Celgene (NASDAQ: CELG)

92.00 0.64 (0.70%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $92.00 0.70%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $91.33
Previous Close $91.36
Daily Range $91.11 - $93.35
52-Week Range $66.29 - $93.35
Market Cap $73.6B
P/E Ratio 52.81
Dividend (Yield) $0.00 (0.0%)
Volume 4,509,428
Average Daily Volume 4,350,704
Current FY EPS $3.18





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

3 Reasons Celgene Corporation's Stock Could Rise

Celgene stock has more than tripled over the past three years, but these three catalysts suggest it could just be getting started.

Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog

3 Drugs Stocks On The Rise

Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog

3 Stocks Reiterated As A Buy: CELG, GE, C

Noteworthy ETF Outflows: IYH, AMGN, BIIB, CELG

Taking Profits From Netflix And Putting Them To Work In Celgene

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and M

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More

Epizyme Holds A Key To A Potential Blockbuster Drug For Hematological Cancers

Celgene (CELG) Hits New Lifetime High

See More CELG News...

CELG's Top Competitors

CELG $92.00 (0.70%)
Current stock: CELG
AMGN $132.68 (-0.26%)
Current stock: AMGN
GILD $100.79 (-0.48%)
Current stock: GILD
$0.00 (0.00%)
Current stock: